Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis.
Walsh
Michael
M
Vasculitis and Lupus Clinic, Department of Renal Medicine, Addenbrooke's Hospital, Cambridge, UK. mwwalsh@ucalgary.ca
Tonelli
Marcello
M
Jayne
David
D
Manns
Braden
B
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D015415:Biomarkers / Q000378:metabolism*; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000639:trends; D012008:Recurrence; D014657:Vasculitis / Q000276:immunology* / Q000378:metabolism*
D019268:Antibodies, Antineutrophil Cytoplasmic; D015415:Biomarkers